1 / 45

Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006

Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006. Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification Protein Chips. Last Time. 1) Insertional Mutagenesis Transposon Strategies

elle
Télécharger la présentation

Gene Disruption (cont) & Protein-Protein Interactions October 4, 2006

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Gene Disruption (cont) & Protein-Protein InteractionsOctober 4, 2006 Outline Recap Gene Disruption and Drug Discovery RNAi Two Hybrid Affinity Purification Protein Chips

  2. Last Time 1) Insertional Mutagenesis • Transposon Strategies • Use reporter constructs to make enhancer traps and gene fusions 2) Systematic Knockouts Bar coded

  3. Yeast Strains With Tagged Knockouts

  4. Functional Analysis of Knockout Strains

  5. Using Deletions to Profile Drug Sensitivity Giaever et al. Nature Genetics 1999 vol 21, 278-283

  6. Using Deletions to Profile Drug Sensitivity YMR007 ALG7 Giaever et al. Nature Genetics 1999 vol 21, 278-283

  7. Using Heterozygous Deletions to Profile Drug Sensitivity(3503 strains 78 Compounds) Lum et al. Cell 2004 Vol 116

  8. Using Heterozygous Deletions to Profile Drug Sensitivity(3503 strains) Lum et al. Cell 2004 Vol 116

  9. C. elegans RNAi = RNA interference + AA dsRNA AAAAA AA mRNA dsRNA inhibits gene expression by degrading its complementary mRNA Fire and Mello 1998 Nature

  10. Genome Wide Approach ORF Clone genes into E. coli Expression vector that makes dsRNA E. coli Feed Worm E. coli; Score phenotype

  11. RNAi 16,757 (86%) C. elegans Genes RNAied; 1,722 Mutant phenotypes Ahringer et al., Kohara et al. Can be used for many organisms Drosophila, Mammalian Cells

  12. Mammalian RNAi Retrovirus Vector Packaging Cells Virus Infect Cells shRNA Expression From RNAi consortium

  13. Identification of Tumor Suppressors Using RNAi Klofcshoten et al. (2005) Cell 121, 849-858 1° Fibroblasts from humans die Tr(-onc) Engineered Fibroblasts (hTERT, small t Antigen, p53-, p16-) “almost transformed” Tr(-onc) Engineered Fibroblasts + RASV12 Transformed and form colonies

  14. Identification of Tumor Suppressors Using RNAi Tr(-onc) cells shRNA library (against 4000 genes) New Tumor Suppressor: PITX1 Klofschoten et al. (2005) Cell 121, 849-858

  15. RNAi Advantages • Simple and Inexpensive • Systematic method--Comprehensive • Knockout expression of gene families Disadvantages • Some Genes Not Affected • Limited alleles • Off target effects

  16. Uses of Knockouts: Summary • Score phenotype to understand gene function • Group different genes together based on phenotype • Find new interesting genes • Drug discovery

  17. Global Protein::Protein Interactions • Three Methods: 1) Two Hybrid 2) Complex Analysis: Affinity tagging/Mass Spectroscopy 3) Protein Chip

  18. Two-Hybrid System For DetectingProtein-Protein Interaction Genes Gal4 DNA Binding Domain Gal4 Activation Domain Protein B Protein A Fusion Proteins Gal4 DNA Binding Sites HIS3 Selectable Marker If A & B interact Colonies Grow On Plates Lacking Histidine HIS3 Expression

  19. DB:: ORF Cloning Strategy Yeast ORFs Primer 1 Primer 2 PCR ATG TAA + Vector coTransform GAL GAL DB

  20. Screening 6200 X 6200 Interactions AD::Protein B Fusion MATa strains HIS3 Containing GalAD construct DB::Protein A Fusion Mate to MATa strain Containing DB construct MATa/MATa Diploids Assay Expression e.g His+ colonies Black = Colonies

  21. Large Scale Two-Hybrid Screening Sequence Adjacent to ORF for each plasmid (Interaction Sequence Tags ISTs)

  22. Results of Two Studies 1) 4,549 Interactions Among 3,278 Proteins (Ito et al.) 2) 957 Interactions 1004 proteins (Utez et al.)

  23. Interaction Map of Spindle Pole Body (MTOC) Proteins

  24. Interaction Map of Vesicular Transport Proteins

  25. A Comprehensive Protein Interaction Map

  26. Overlap of the Two Hybrid Studies Utez et al Pool Approach Ito et al Pool Approach 541 135 691 6 9 9 257 Utez et al. Individual Screen

  27. Human Two Hybrid Screen 8,100 X 8,100 ORFs (~7,200 genes) (1 DB clone X pool of 188 AD clones) 10,597 Interactions 2,754 Nonredundant Rual et al. Nature 2005

  28. Human Two Hybrid Map Rual et al. Nature 2005

  29. Human Two Hybrid MapDisease Genes (121 genes (green)) Rual et al. Nature 2005 Vol 437

  30. Two Hybrid Advantages - In vivo Assay - Fairly Simple Disadvantages - Hard to execute on a large scale - Prone to artifacts 50% False +s - Interactions mediated in nucleus

  31. Tandem Affinity Purification (TAP) Tagging Protein A (IgG Binding) Cam-Binding Domain ORF TEV

  32. YFP YFP YFP TAP Approach Contaminants IgG Beads Protein A Purification YFP Associated Proteins TEV Protease, CBD Purification Cam Beads Elute EGTA

  33. Identify Proteins by Mass Spec Load on SDS Gel Excise Band; Digest with Trypsin; Run Mass Spec

  34. TAP Purification of The U1 Splicing Complex (Snu71p) (New) (New)

  35. Many Complexes Are Conserved

  36. Affinity Purification/Mass Spec Analysis of Complexes - Yeast 4,562 Purifications (Krogan et al. 2002) 2,357 Successful 4,087 Interacting Proteins 7,123 Core Interactions (2,708 proteins) 14,317 Extended (3,672 proteins) 547 Complexes Krogan et al. Nature 2006 Vol 440

  37. Size and Conservation of the Complexes Two Hybrid

  38. TAP Tag Approach Advantages - In Vivo Assay - Identifies Entire Complex Disadvantages - Interactions may be indirect - Likely to miss some rare components - Contaminants may copurify

  39. Summary • Affinity Purification: ~10,000 High Confidence Interactions Among ~2000 Proteins • Two Hybrid: >4,549 Interactions Among 3,278 Proteins • >20,000 Interactions • Combining Data = More Accuracy

  40. What is a Protein Microarray? A high density array containing 100s to many thousands of proteins

  41. Awesome DNA Microarrays • Analyzing Gene Expression • Mapping Mutations • Mapping Transcription Factor Binding Sites

  42. Awesome2 Protein Microarrays • Protein Function • Protein Modification and Regulation • Protein Pathways • Protein Profiling • Drug Discovery and Development

  43. Protein-Protein Interactions Small Molecule Interactions Enzymatic Assays ATP ADP Two Types of Protein Microarrays Antibody Microarrays Functional Protein Microarrays Antigens

  44. Cytokine Detection withAntibody Microarray Microarray assay of a human serum sample. A 15 µL sample of human serum was incubated for 30 min on a microarray with 75 different anticytokine antibodies printed in quadruplicate. Following washing and incubation with a mixture of secondary antibodies to each cytokine, detection was carried out using RCA. The fluorescent image was obtained using GenePix software on an Axon Microarray Scanner. The enlarged image shown represents one-eighth of the data acquired from a 1' × 3' microscope slide. Fluorescent intensities are represented in pseudocolor, with lowest intensities in blue and highest intensities in white.

  45. Human Allergen Microarray

More Related